COVID-19: the vasculature unleashed
Open Access
- 1 July 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 20 (7), 389-391
- https://doi.org/10.1038/s41577-020-0343-0
Abstract
On the basis of emerging evidence from patients with COVID-19, we postulate that endothelial cells are essential contributors to the initiation and propagation of severe COVID-19. Here, we discuss current insights into the link between endothelial cells, viral infection and inflammatory changes and propose novel therapeutic strategies.This publication has 10 references indexed in Scilit:
- Endothelial cell infection and endotheliitis in COVID-19The Lancet, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJama-Journal Of The American Medical Association, 2020
- An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates (vol 37, pg 21.e1, 2020)Cancer Cell, 2020
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Single-Cell Transcriptome Atlas of Murine Endothelial CellsCell, 2020
- Hallmarks of Endothelial Cell Metabolism in Health and DiseaseCell Metabolism, 2019
- Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus InfectionCell, 2011
- Platelets, Petechiae, and Preservation of the Vascular WallThe New England Journal of Medicine, 2008
- Evolving functions of endothelial cells in inflammationNature Reviews Immunology, 2007